people with advanced cancer: ID1127727. Ref: Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2016: Development Collaborative Walter and Eliza of a Clinico-Molecular Colon Cancer Cancer Hall Institute of Cancer Nomogram for $594,254.00 08/03/2017 36 Parkville 3052 Australia Research Medical Research personalisation of adjuvant Scheme chemotherapy in the Australian population: ID1120882. Ref: CA-G1516/56 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and Priority Driven positron emission tomography Collaborative Cancer University of (PET)/CT surveillance imaging The University of Cancer $481,698.00 08/03/2017 36 2006 Australia Sydney in asymptomatic Stage III Sydney Research melanoma patients - a Scheme prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing Priority Driven glucocorticoid resistance in Collaborative Lowy Cancer Cancer paediatric acute Cancer Research Centre, $296,428.50 10/03/2017 36 Kensington 2052 Australia lymphoblastic leukaemia - a Research University of NSW novel epigenetic mechanism Scheme linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52 Priority Driven Collaborative Priority Driven Cancer Research Scheme Collaborative (PDCCRS) 2016: ASCOLT: Cancer University of The University of Cancer Aspirin for Dukes C and High $213,459.53 17/03/2017 36 2006 Australia Sydney Sydney Research Risk Dukes B Colorectal Scheme Cancers. An International, Multi-centre, Double Blind,
people with advanced cancer: ID1127727. Ref: Cancer Australia Priority Driven Collaborative Cancer Research Scheme Walter and Eliza Hall Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Development of a Clinico-Molecular Colon Cancer Nomogram for personalisation of adjuvant chemotherapy in the Australian population: ID1120882. Ref: CA-G1516/56 $594,254.00 08/03/2017 36 Parkville 3052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57 $481,698.00 08/03/2017 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Lowy Cancer Research Centre, University of NSW Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia - a novel epigenetic mechanism linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52 $296,428.50 10/03/2017 36 Kensington 2052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, $213,459.53 17/03/2017 36 The University of Sydney 2006
grants_reporting_20170922.docx